Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with

KeepHealthCare.ORG – Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with The planned Phase Ib/II, open-label, multicenter, randomized trial will enroll patients with metastatic HR+, HER2- breast cancer Continue reading